| OPHT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OPHT shares outstanding history going back to 9/25/2013:
Also see: OPHT Market Cap History OPHT YTD Return |
As of 2/27/2019 Ophthotech has 41.42 million OPHT shares outstanding. Investors often track the OPHT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OPHT share count trends over time, with 23 historical shares outstanding datapoints presented, dating back to 9/25/2013.

| OPHT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OPHT shares outstanding history going back to 9/25/2013:
Also see: OPHT Market Cap History OPHT YTD Return |
| OPHT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
OPHT Historical Shares Outstanding: +7.32% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| OPHT Stock Price Chart |
| About IVERIC bio Inc |
| Ophthotech is a biopharmaceutical company focusing on the development of therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Co. is developing Zimura® (avacincaptad pegol), its complement C5 inhibitor, for dry and wet forms of age-related macular degeneration, which is a disorder of the central portion of the retina, known as the macula, that may result in loss of central vision, and autosomal recessive Stargardt disease, which is an orphan inherited retinal disease that also may result in loss of central and peripheral vision. We show 23 historical shares outstanding datapoints in our coverage of OPHT's shares outstanding history. Understanding the changing numbers of OPHT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OPHT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OPHT by allowing them to research OPHT shares outstanding history as well as any other stock in our coverage universe. |
| OPHT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| OPHT Share Performance |
| Shares Outstanding Peers |
| Ophthotech (OPHT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OPK Shares Outstanding History OPNT Shares Outstanding History OPTN Shares Outstanding History ORGO Shares Outstanding History ORGS Shares Outstanding History ORIC Shares Outstanding History ORKA Shares Outstanding History ORMP Shares Outstanding History OSA Shares Outstanding History OSH Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.